Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 14, Pages 5025
Publisher
MDPI AG
Online
2020-07-16
DOI
10.3390/ijms21145025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dietary supplements in dermatology: a review of the evidence for zinc, biotin, vitamin D, nicotinamide, and polypodium
- (2020) Katherine G. Thompson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma
- (2019) Sonia Brun et al. INVESTIGATIONAL NEW DRUGS
- The Therapeutic Potential of Apigenin
- (2019) Bahare Salehi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma
- (2019) Marie R. Webster et al. MOLECULAR CELL
- Nutraceuticals: opening the debate for a regulatory framework
- (2018) Antonello Santini et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
- (2018) Jennifer Tsoi et al. CANCER CELL
- Toward Minimal Residual Disease-Directed Therapy in Melanoma
- (2018) Florian Rambow et al. CELL
- Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids
- (2018) Un-Ho Jin et al. TOXICOLOGICAL SCIENCES
- Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
- (2018) Farzana Ahmed et al. Frontiers in Oncology
- Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
- (2018) Lu Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
- (2018) Sébastien Corre et al. Nature Communications
- Flavonoids in Cancer and Apoptosis
- (2018) Mariam Abotaleb et al. Cancers
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- Targeting invasive properties of melanoma cells
- (2017) Imanol Arozarena et al. FEBS Journal
- Anti-Inflammatory and Neuroprotective Effect of Apigenin: Studies in the GFAP-IL6 Mouse Model of Chronic Neuroinflammation
- (2017) H Liang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma
- (2017) Xian Chan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development and evaluation of injectable nanosized drug delivery systems for apigenin
- (2017) Reatul Karim et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
- (2017) Pablo Angulo et al. Journal of Hematology & Oncology
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells
- (2017) Guangming Zhao et al. ONCOLOGY REPORTS
- Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development
- (2017) Karine A. Cohen-Solal et al. Pigment Cell & Melanoma Research
- Recurrent Tumor Cell–Intrinsic and –Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
- (2017) Chunying Song et al. Cancer Discovery
- Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
- (2017) Xiaohui Yan et al. Cell and Bioscience
- Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling
- (2016) Jasmina Paluncic et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB
- (2016) A. A. N. Rose et al. CLINICAL CANCER RESEARCH
- Chrysin, Abundant in Morinda citrifolia Fruit Water–EtOAc Extracts, Combined with Apigenin Synergistically Induced Apoptosis and Inhibited Migration in Human Breast and Liver Cancer Cells
- (2016) Cheng Huang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial
- (2016) Jun J. Mao et al. PHYTOMEDICINE
- Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway
- (2016) MIN XU et al. Oncology Letters
- Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
- (2015) Gatien Moriceau et al. CANCER CELL
- Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis
- (2015) Ming-Der Shi et al. Cancer Cell International
- Consumption of Soy Isoflavone Enriched Bread in Men with Prostate Cancer Is Associated with Reduced Proinflammatory Cytokines and Immunosuppressive Cells
- (2015) G. B. Lesinski et al. Cancer Prevention Research
- Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression
- (2015) V. da Silva-Diz et al. CANCER RESEARCH
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- Efficacy and safety of topical Matricaria chamomilla L. (chamomile) oil for knee osteoarthritis: A randomized controlled clinical trial
- (2015) Ruhollah Shoara et al. Complementary Therapies in Clinical Practice
- Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy
- (2014) K. Kemper et al. CANCER RESEARCH
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- p53 Requires the Stress Sensor USF1 to Direct Appropriate Cell Fate Decision
- (2014) Amine Bouafia et al. PLoS Genetics
- Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
- (2013) Stephen Safe et al. TOXICOLOGICAL SCIENCES
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
- (2013) N. Wagle et al. Cancer Discovery
- Biopharmaceutics classification and intestinal absorption study of apigenin
- (2012) Jianjun Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
- (2012) Maria R. Girotti et al. Cancer Discovery
- PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
- (2011) K. H. T. Paraiso et al. CANCER RESEARCH
- RNAi-Based Screening Identifies Kinases Interfering with Dioxin-Mediated Up-Regulation of CYP1A1 Activity
- (2011) David Gilot et al. PLoS One
- Suppression mechanisms of flavonoids on aryl hydrocarbon receptor-mediated signal transduction
- (2010) Rie Mukai et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- The aryl hydrocarbon receptor: fine-tuning the immune-response
- (2010) Marc Veldhoen et al. CURRENT OPINION IN IMMUNOLOGY
- Bioavailability Challenges Associated with Development of Anti-Cancer Phenolics
- (2010) S. Gao et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Activation of the Aryl Hydrocarbon Receptor by the Calcium/Calmodulin-Dependent Protein Kinase Kinase Inhibitor 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid (STO-609)
- (2008) P. Monteiro et al. DRUG METABOLISM AND DISPOSITION
- Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin
- (2008) Li-Tao Yi et al. LIFE SCIENCES
- Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence
- (2008) Harald Hoensch et al. WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now